Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China
· Delayed Price · Currency is CNY 4.360
+0.010 (0.23%)
Mar 10, 2026, 10:25 AM CST
SHA:600572 Revenue
Zhejiang CONBA Pharmaceutical had revenue of 1.62B CNY in the quarter ending September 30, 2025, with 10.42% growth. This brings the company's revenue in the last twelve months to 6.58B, up 1.80% year-over-year. In the year 2024, Zhejiang CONBA Pharmaceutical had annual revenue of 6.52B, down -3.23%.
Revenue (ttm)
6.58B
Revenue Growth
+1.80%
P/S Ratio
1.68
Revenue / Employee
782.04K
Employees
8,411
Market Cap
11.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.52B | -217.63M | -3.23% |
| Dec 31, 2023 | 6.73B | 732.35M | 12.20% |
| Dec 31, 2022 | 6.00B | -567.74M | -8.64% |
| Dec 31, 2021 | 6.57B | 659.17M | 11.16% |
| Dec 31, 2020 | 5.91B | -859.28M | -12.70% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Foyou Pharma CO.,LTD | 3.42B |
| Mayinglong Pharmaceutical Group | 3.77B |
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 5.49B |
| Wanbangde Pharmaceutical Holding Group | 1.39B |
| Porton Pharma Solutions | 3.43B |
| Shanghai Yizhong Pharmaceutical | 317.08M |
| Yantai Dongcheng Pharmaceutical Group | 2.75B |
| North China Pharmaceutical Company.Ltd | 9.79B |